Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
about
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: a report of 10 cases (2005-2011).Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma.Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.TOLERABILITY AND TUMOR RESPONSE OF A NOVEL LOW-DOSE PALLIATIVE RADIATION THERAPY PROTOCOL IN DOGS WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER AND URETHRA.Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors.Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.Anatomical and physiological basis for the allometric scaling of cisplatin clearance in dogs.Adjuvant therapy for highly malignant canine mammary tumours: Cox-2 inhibitor versus chemotherapy: a case-control prospective study.Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies.
P2860
Q33593041-4ACF27FF-590F-461B-9735-592CD7880A7CQ34699882-62441DC4-DF5A-48AC-98F0-36E2888FEFFDQ35251869-FF6F53E7-49A8-4480-AEDE-6354E0723991Q36873717-994D0C30-E78C-43D3-AE88-98058263DE33Q37053781-14F118F9-FD70-49C9-BA74-790185FCB684Q38220806-4205B21E-1E7C-45AF-8EEF-09810F645F5CQ38912582-B3DB4629-0436-4814-9B1F-B6C3E5AA7DC8Q39436032-454D9E42-FBEF-4253-BDCC-505C12920544Q48104915-2D0BE0A7-45F2-4308-80FC-937C41356132Q48109905-B8D0E7CE-B258-4729-AE40-C535A66DDADDQ50798269-B205D6EA-D347-40F2-8E56-7A22C1B15711Q53073419-4B2F2AE0-459D-4E2E-987D-AE3D491CBFDCQ55081994-E163B0A8-DB22-44FB-BB79-8112265FA5B0
P2860
Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@en
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@nl
type
label
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@en
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@nl
prefLabel
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@en
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@nl
P2093
P2860
P356
P1476
Randomized trial of cisplatin ...... cinoma of the urinary bladder.
@en
P2093
C B Greenberg
J A Ramos-Vara
M D Lucroy
P D Hanson
P L Bonney
P2860
P304
P356
10.1111/JVIM.12013
P577
2012-12-03T00:00:00Z